ClinicalTrials.govpublic full text
A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden
metastatic castration resistant prostate cancer, enzalutamide, metastatic castration-resistant prostate cancer, xtandi, registry based study, mdv3100, mcrpc, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 866968
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.